Xenon Pharmaceuticals Inc (XENE)
42.53
-0.40
(-0.93%)
USD |
NASDAQ |
May 09, 14:24
Xenon Pharmaceuticals Total Assets (Quarterly): 964.80M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 964.80M |
| September 30, 2023 | 671.09M |
| June 30, 2023 | 684.90M |
| March 31, 2023 | 719.87M |
| December 31, 2022 | 754.15M |
| September 30, 2022 | 775.81M |
| June 30, 2022 | 807.38M |
| March 31, 2022 | 558.06M |
| December 31, 2021 | 572.01M |
| September 30, 2021 | 264.35M |
| June 30, 2021 | 274.71M |
| March 31, 2021 | 290.67M |
| December 31, 2020 | 189.19M |
| September 30, 2020 | 199.13M |
| June 30, 2020 | 210.68M |
| March 31, 2020 | 237.04M |
| December 31, 2019 | 147.70M |
| September 30, 2019 | 98.90M |
| June 30, 2019 | 105.89M |
| March 31, 2019 | 114.55M |
| Date | Value |
|---|---|
| December 31, 2018 | 122.43M |
| September 30, 2018 | 130.46M |
| June 30, 2018 | 65.44M |
| March 31, 2018 | 37.76M |
| December 31, 2017 | 46.12M |
| September 30, 2017 | 46.36M |
| June 30, 2017 | 54.23M |
| March 31, 2017 | 60.79M |
| December 31, 2016 | 67.49M |
| September 30, 2016 | 73.37M |
| June 30, 2016 | 55.69M |
| March 31, 2016 | 61.15M |
| December 31, 2015 | 63.95M |
| September 30, 2015 | 69.94M |
| June 30, 2015 | 76.53M |
| March 31, 2015 | 79.40M |
| December 31, 2014 | 87.42M |
| September 30, 2014 | 54.14M |
| June 30, 2014 | 50.71M |
| December 31, 2013 | 54.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
98.90M
Minimum
Sep 2019
964.80M
Maximum
Dec 2023
448.75M
Average
290.67M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| ESSA Pharma Inc | 144.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.88M |
| Shareholders Equity (Quarterly) | 927.92M |